tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rigel Pharmaceuticals: First patient enrolled in Phase 1b study of R289
PremiumThe FlyRigel Pharmaceuticals: First patient enrolled in Phase 1b study of R289
28d ago
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth
Premium
Company Announcements
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth
3M ago
Rigel’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
Premium
Ratings
Rigel’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
3M ago
Promising Efficacy and Market Potential for GAVRETO in RET Fusion-Positive Tumors
PremiumRatingsPromising Efficacy and Market Potential for GAVRETO in RET Fusion-Positive Tumors
5M ago
Rigel Pharmaceuticals Approves Equity Plan Amendment
Premium
Company Announcements
Rigel Pharmaceuticals Approves Equity Plan Amendment
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
Rigel Pharmaceuticals reports Q1 EPS 63c vs. 47c last year
PremiumThe FlyRigel Pharmaceuticals reports Q1 EPS 63c vs. 47c last year
6M ago
RIGL Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RIGL Earnings this Week: How Will it Perform?
6M ago
Rigel Pharmaceuticals resolves patent litigation related to Tavalisse
Premium
The Fly
Rigel Pharmaceuticals resolves patent litigation related to Tavalisse
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100